{
  "abstract": "Primary biliary cholangitis (PBC) is a chronic, progressive autoimmune liver disease, characterised by widespread inflammation and scarring in the liver, accompanied by damage to and loss of the intrahepatic bile ducts. 1 2 Over the past decade, there have been significant advances in our understanding of PBC pathophysiology, resulting in the development of better therapies, personalised medicine, introduction of risk stratification and reduced PBC stigma.1 3 4 However, there is still room to improve care of people living with PBC.",
  "authors": [
    {
      "affiliations": [
        "PBC Foundation, Edinburgh, UK"
      ],
      "name": "Robert Mitchell-Thain"
    },
    {
      "affiliations": [
        "Ipsen Group, London, UK"
      ],
      "name": "Alexander Artyomenko"
    },
    {
      "affiliations": [
        "Gastroenterology, Walton Liver Clinic, Glasgow Royal Infirmary, NHS Greater Glasgow and Clyde, Glasgow, Glasgow, UK"
      ],
      "name": "Stephen Barclay"
    },
    {
      "affiliations": [
        "Gastroenterology/Hepatology, Beth Israel Deaconnes Medical Center, Boston, Massachusetts, USA"
      ],
      "name": "Alan Bonder"
    },
    {
      "affiliations": [
        "Calliditas Therapeutics AB, Stockholm, Sweden"
      ],
      "name": "Stefan Carlsson"
    },
    {
      "affiliations": [
        "PBC Foundation, Edinburgh, UK"
      ],
      "name": "Mo Christie"
    },
    {
      "affiliations": [
        "Translational Gastroenterology and Liver Unit, John Radcliffe Hospital, Oxford, and Nuffield Department of Medicine, University of Oxford, Oxford, UK"
      ],
      "name": "Emma L Culver"
    },
    {
      "affiliations": [
        "Niguarda Liver Centre, University of Milan-Bicocca, Milan, Lombardy, Italy"
      ],
      "name": "Daphne D’Amato"
    },
    {
      "affiliations": [
        "CymaBay Therapeutics, Newark, California, USA"
      ],
      "name": "Klara Dickinson"
    },
    {
      "affiliations": [
        "Hepatitis B Foundation, Doylestown, Pennsylvania, USA"
      ],
      "name": "Robert Gish"
    },
    {
      "affiliations": [
        "Erasmus MC University Medical Center Rotterdam, Rotterdam, ZH, The Netherlands",
        "Toronto Centre for Liver Disease, University of Toronto, Toronto, Ontario, Canada"
      ],
      "name": "Bettina E Hansen"
    },
    {
      "affiliations": [
        "Albi Association Spain, Barcelona, Spain"
      ],
      "name": "Gema Iribar"
    },
    {
      "affiliations": [
        "Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, ZH, Switzerland"
      ],
      "name": "Andreas E Kremer"
    },
    {
      "affiliations": [
        "Division of Digestive Health and Liver Diseases, University of Miami School of Medicine, Miami, Florida, USA"
      ],
      "name": "Cynthia Levy"
    },
    {
      "affiliations": [
        "CymaBay Therapeutics, Newark, California, USA"
      ],
      "name": "Jonathan Ieyoub"
    },
    {
      "affiliations": [
        "Ipsen Group, Cambridge, Massachusetts, USA"
      ],
      "name": "Benjamin Miller"
    },
    {
      "affiliations": [
        "Save Liver Association, Prilep, North Macedonia"
      ],
      "name": "Biljana Mirceska"
    },
    {
      "affiliations": [
        "Calliditas Therapeutics AB, Stockholm, Sweden"
      ],
      "name": "Krassimir Mitchev"
    },
    {
      "affiliations": [
        "Rare Liver Diseases, Hepatitis Aid, Vienna, Austria"
      ],
      "name": "Margit Paul"
    },
    {
      "affiliations": [
        "Ipsen Group, Boulogne-Billancourt, Île-de-France, France"
      ],
      "name": "Marwan Sleiman"
    },
    {
      "affiliations": [
        "Department of Medicine, University of Calgary, Calgary, Alberta, Canada"
      ],
      "name": "Mark G Swain"
    },
    {
      "affiliations": [
        "Department of Medicine, Teikyo University School of Medicine, Itabashi, Tokyo, Japan"
      ],
      "name": "Atsushi Tanaka"
    },
    {
      "affiliations": [
        "Mijnlever, Brussels, Belgium"
      ],
      "name": "Robert Tomsin"
    },
    {
      "affiliations": [
        "Queen Elizabeth Hospital Birmingham, Birmingham, UK"
      ],
      "name": "Palak Trivedi"
    },
    {
      "affiliations": [
        "GSK, London, UK"
      ],
      "name": "Philip J F Troke"
    },
    {
      "affiliations": [
        "Deutsche Leberhilfe e.V, Köln, Germany"
      ],
      "name": "Ingo van Thiel"
    },
    {
      "affiliations": [
        "Department of Gastroenterology and Hepatology, Nepean Hospital, Penrith, New South Wales, Australia",
        "Nepean Clinical School, The University of Sydney, Penrith, New South Wales, Australia"
      ],
      "name": "Martin Weltman"
    },
    {
      "affiliations": [
        "Liver Patients International, Brussels, Belgium"
      ],
      "name": "José Willemse"
    },
    {
      "affiliations": [
        "Gwent Liver Unit, Aneurin Bevan University Health Board, Newport, UK"
      ],
      "name": "Andrew Yeoman"
    },
    {
      "affiliations": [
        "Niguarda Liver Centre, University of Milan-Bicocca, Milan, Lombardy, Italy"
      ],
      "name": "Marco Carbone"
    },
    {
      "affiliations": [
        "Newcastle University School of Medicine, Newcastle upon Tyne, UK"
      ],
      "name": "David Jones"
    }
  ],
  "title": "Challenges facing the PBC community: insights from the PBC International Summit",
  "uid": "22063a13-a989-57e8-861c-a0906886ca2c"
}
